Page last updated: 2024-09-05

sorafenib and tamibarotene

sorafenib has been researched along with tamibarotene in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(tamibarotene)
Trials
(tamibarotene)
Recent Studies (post-2010) (tamibarotene)
6,5207305,25119810105

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)tamibarotene (IC50)
Chain A, PROTEIN (CRABP-I)Bos taurus (cattle)0.14
Chain A, PROTEIN (CRABP-II)Homo sapiens (human)0.14
Chain A, PROTEIN (CRABP-II)Homo sapiens (human)0.14
Retinoic acid receptor alphaHomo sapiens (human)0.078

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishijima, N; Kanki, K; Shimizu, H; Shiota, G1

Other Studies

1 other study(ies) available for sorafenib and tamibarotene

ArticleYear
Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib.
    Cancer science, 2015, Volume: 106, Issue:5

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzoates; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Retinoids; Sorafenib; Tetrahydronaphthalenes; Tretinoin

2015